New York State Jury Finds Manufacturer Teva and Distributor Anda Liable for Fueling Opioid Epidemic in New York State - Simmons Hanly Conroy
Teva: Dr. Reddy's buys eight ANDAs from Teva for $350 million - The Economic Times
Teva's Generic Value Chain Differentiates It from Its Peers
Teva brochure for Institutional Medicine Sales | Behance
Who We Are | AndaNet
Teva buys Allergan distributor Anda for $500m - Globes
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
New York Opioid Trial: Allergan Settlement Leaves Teva as Last Target - Bloomberg
Dr Reddy's completes acquisition of 8 Teva ANDAs - The Hindu BusinessLine
Teva buys Anda for $500 million - ISRAEL21c
Teva Takes Aim At First Truvada And Atripla Generics In US :: Generics Bulletin
San Francisco reaches $58 mln opioid settlement with Teva, Allergan | Reuters
Teva to pay New York $500M for role in opioid crisis - POLITICO
Allergan sells Anda to Teva for $500 million - CDR – Chain Drug Review
Teva to Buy Generics Distributor Anda From Allergan for $500 Million - WSJ
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Allergan sells Anda to Teva for $500 million - CDR – Chain Drug Review
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Holds off Huntington's Competitor, Resolves Opioid Cases | BioSpace
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
What GSK v. Teva Means for ANDA Skinny Labels
Anda - Crunchbase Company Profile & Funding
Teva Completes Acquisition of Anda Inc | World Pharma Today
Teva Pharmaceuticals USA and Anda, Inc.... - Kids In Distress | Facebook
